InsiderClue
Stocks · Health care · Services-Medical Laboratories

Fulgent Genetics, Inc.

FLGT Clue Score26
United States Fiscal year ends December CIK 0001674930
$21.74 +4.42% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $21.74 −74.06% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue18.3Operating income0.9Net income−5.3Fiscal year 2017Revenue18.7 +2.5%Operating income−3.5Net income−2.5EPS, diluted−0.14Fiscal year 2018Revenue21.4 +14.0%Operating income−5.1Net income−5.6EPS, diluted−0.31Fiscal year 2019Revenue32.5 +52.3%Operating income−0.4Net income−0.4EPS, diluted−0.02Fiscal year 2020Revenue421.7 +1,196.5%Operating income290.2Net income214.3EPS, diluted8.91Fiscal year 2021Revenue992.6 +135.4%Operating income676.0Net income507.4 +136.7%EPS, diluted16.38 +83.8%Fiscal year 2022Revenue619.0 −37.6%Operating income178.5Net income143.4 −71.7%EPS, diluted4.63 −71.7%Fiscal year 2023Revenue289.2 −53.3%Operating income−195.5Net income−167.8 −217.0%EPS, diluted−5.63 −221.6%Fiscal year 2024Revenue283.5 −2.0%Operating income−73.9Net income−42.7EPS, diluted−1.41Fiscal year 2025Revenue322.7 +13.8%Operating income−91.1Net income−60.5EPS, diluted−1.97
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 18.3 18.7 21.4 32.5 421.7 992.6 619.0 289.2 283.5 322.7
Growth +2.5% +14.0% +52.3% +1,196.5% +135.4% −37.6% −53.3% −2.0% +13.8%
Operating income 0.9 −3.5 −5.1 −0.4 290.2 676.0 178.5 −195.5 −73.9 −91.1
Net income −5.3 −2.5 −5.6 −0.4 214.3 507.4 143.4 −167.8 −42.7 −60.5
Growth +136.7% −71.7% −217.0%
EPS, diluted n/a −0.14 −0.31 −0.02 8.91 16.38 4.63 −5.63 −1.41 −1.97
Growth +83.8% −71.7% −221.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin63.2%Operating margin5.0%Net margin−29.3%Free cash flow margin3.4%Fiscal year 2017Gross margin54.3%Operating margin−18.6%Net margin−13.4%Free cash flow margin−8.4%Fiscal year 2018Gross margin49.9%Operating margin−23.7%Net margin−26.3%Free cash flow margin−14.0%Fiscal year 2019Gross margin56.6%Operating margin−1.3%Net margin−1.3%Free cash flow margin13.3%Fiscal year 2020Gross margin78.7%Operating margin68.8%Net margin50.8%Free cash flow margin25.0%Fiscal year 2021Gross margin78.3%Operating margin68.1%Net margin51.1%Free cash flow margin51.9%Fiscal year 2022Gross margin59.3%Operating margin28.8%Net margin23.2%Free cash flow margin37.9%Fiscal year 2023Gross margin36.1%Operating margin−67.6%Net margin−58.0%Free cash flow margin1.7%Fiscal year 2024Gross margin37.8%Operating margin−26.1%Net margin−15.1%Free cash flow margin−6.8%Fiscal year 2025Gross margin40.6%Operating margin−28.2%Net margin−18.8%Free cash flow margin−38.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 63.2% 54.3% 49.9% 56.6% 78.7% 78.3% 59.3% 36.1% 37.8% 40.6%
Operating margin 5.0% −18.6% −23.7% −1.3% 68.8% 68.1% 28.8% −67.6% −26.1% −28.2%
Net margin −29.3% −13.4% −26.3% −1.3% 50.8% 51.1% 23.2% −58.0% −15.1% −18.8%
Free cash flow margin 3.4% −8.4% −14.0% 13.3% 25.0% 51.9% 37.9% 1.7% −6.8% −38.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow4.4Capital expenditure−3.8Free cash flow0.6Fiscal year 2017Operating cash flow1.3Capital expenditure−2.9Free cash flow−1.6 −353.5%Fiscal year 2018Operating cash flow−0.7Capital expenditure−2.3Free cash flow−3.0Fiscal year 2019Operating cash flow5.5Capital expenditure−1.2Free cash flow4.3Buybacks−0.0Fiscal year 2020Operating cash flow140.6Capital expenditure−35.1Free cash flow105.5 +2,333.6%Buybacks−0.1Fiscal year 2021Operating cash flow538.6Capital expenditure−23.8Free cash flow514.8 +387.9%Fiscal year 2022Operating cash flow253.5Capital expenditure−18.8Free cash flow234.7 −54.4%Buybacks−74.3Fiscal year 2023Operating cash flow27.0Capital expenditure−22.2Free cash flow4.8 −98.0%Buybacks−25.1Fiscal year 2024Operating cash flow21.1Capital expenditure−40.3Free cash flow−19.3 −501.5%Buybacks−0.2Fiscal year 2025Operating cash flow−101.6Capital expenditure−22.6Free cash flow−124.2Buybacks−10.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 4.4 1.3 −0.7 5.5 140.6 538.6 253.5 27.0 21.1 −101.6
Capital expenditure −3.8 −2.9 −2.3 −1.2 −35.1 −23.8 −18.8 −22.2 −40.3 −22.6
Free cash flow 0.6 −1.6 −3.0 4.3 105.5 514.8 234.7 4.8 −19.3 −124.2
Growth −353.5% +2,333.6% +387.9% −54.4% −98.0% −501.5%
Buybacks n/a n/a n/a −0.0 −0.1 n/a −74.3 −25.1 −0.2 −10.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash7.9Shareholders’ equity54.5Fiscal year 2017Cash6.5Shareholders’ equity54.2Fiscal year 2018Cash6.7Shareholders’ equity51.2Fiscal year 2019Cash12.0Shareholders’ equity82.8Fiscal year 2020Cash87.4Shareholders’ equity569.4Fiscal year 2021Cash164.9Shareholders’ equity1,158.7Fiscal year 2022Cash79.5Shareholders’ equity1,266.7Fiscal year 2023Cash97.5Shareholders’ equity1,136.1Fiscal year 2024Cash55.1Shareholders’ equity1,133.2Fiscal year 2025Cash50.2Shareholders’ equity1,112.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.9 6.5 6.7 12.0 87.4 164.9 79.5 97.5 55.1 50.2
Shareholders’ equity 54.5 54.2 51.2 82.8 569.4 1,158.7 1,266.7 1,136.1 1,133.2 1,112.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
18.3 18.7 21.4 32.5 421.7 992.6 619.0 289.2 283.5 322.7
Growth +2.5% +14.0% +52.3% +1,196.5% +135.4% −37.6% −53.3% −2.0% +13.8%
6.7 8.6 10.7 14.1 89.8 215.5 252.1 184.8 176.3 191.8
11.6 10.2 10.7 18.4 331.9 777.1 366.9 104.5 107.2 130.9
Growth −11.9% +4.7% +72.9% +1,701.8% +134.1% −52.8% −71.5% +2.6% +22.1%
3.6 4.2 5.5 6.5 11.6 24.2 28.9 41.4 48.8 53.9
4.6 5.2 5.5 6.4 15.2 50.7 111.1 89.0 88.1 116.7
0.9 −3.5 −5.1 −0.4 290.2 676.0 178.5 −195.5 −73.9 −91.1
Growth −479.3% +133.0% −73.6% −209.5%
−4.5 −3.0 −4.6 0.4 291.7 677.3 184.0 −174.1 −52.0 −70.0
0.9 −1.0 0.0 0.0 72.5 174.8 42.1 1.2 −8.1 −8.4
−5.3 −2.5 −5.6 −0.4 214.3 507.4 143.4 −167.8 −42.7 −60.5
Growth +136.7% −71.7% −217.0%
Per share
n/a −0.14 −0.31 −0.02 9.44 17.25 4.76 −5.63 −1.41 −1.97
n/a −0.14 −0.31 −0.02 8.91 16.38 4.63 −5.63 −1.41 −1.97
Growth +83.8% −71.7% −221.6%
n/a 17.7 18.0 18.7 22.7 29.4 30.1 29.8 30.2 30.8
n/a 17.7 18.0 18.7 24.1 31.0 31.0 29.8 30.2 30.8
Growth +1.3% +4.1% +28.6% +28.8% −0.0% −3.8% +1.5% +1.8%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 5.2% a year over five years.
  • The diluted share count rose 27.9% in five years, which is dilution.
  • Operating margin is down 97.0 points on five years ago, at -28.2%.
  • A net loss in 7 of 10 years on file.